Author:
Sounderrajan Vignesh,Rajadas Sam Ebenezer,Thangam T.,Rao Sudhanarayani S.,Parthasarathy Krupakar,Tamilanban Rohini,Harshavardhan Shakila
Publisher
Springer Nature Singapore
Reference83 articles.
1. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 2007;7(5):328–37.
2. Kolloli A, Subbian S. Host-directed therapeutic strategies for tuberculosis. Front Med (Lausanne) [Internet]. 2017;4:171. https://www.frontiersin.org/articles/10.3389/fmed.2017.00171.
3. Harshavardhan S, Vijayakumar KK, Sounderrajan V, Ramasamy P, Rajadas SE. Chapter 1—Basics of tuberculosis disease and principles of treatment and their effects. In: Rajan M, editor. A mechanistic approach to medicines for tuberculosis nanotherapy [Internet]. Academic; 2021. p. 1–29. https://www.sciencedirect.com/science/article/pii/B9780128199855000115.
4. Krug S, Parveen S, Bishai WR. Host-directed therapies: modulating inflammation to treat tuberculosis. Front Immunol [Internet]. 2021;12:660916. https://www.frontiersin.org/articles/10.3389/fimmu.2021.660916.
5. Young C, Walzl G, Du Plessis N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol [Internet]. 2020;13(2):190–204. https://doi.org/10.1038/s41385-019-0226-5.